What is LabMed National Audit Day?
LabMed’s National Audit Day is a dedicated one-day event showcasing the latest national and regional clinical audits in laboratory medicine, led by Clinical Scientists and Medical professionals across the UK.
Whether you’re directly involved in audits, use audit data to improve patient care, or want to stay ahead of developments in diagnostic service quality — this is an essential event to attend.
The event takes place at the Royal College of Pathologists in London. We will also be live streaming the event. Just select in person or online when you purchase your ticket.
Why attend?
Hear firsthand about current and future national audits, and how they’re shaping best practice
Learn from leading experts in prostate cancer, testosterone, menopause, and tumour marker diagnostics
Engage in discussion with peers and national leads on improving quality across laboratory medicine
Network with professionals and explore audit posters from across the UK
CPD opportunity – supporting your continued professional development
Who should attend?
Clinical Scientists
Laboratory Medicine Consultants
Pathology audit leads
Trainees
Quality Managers
Anyone involved in clinical audit, service improvement, or diagnostics
Programme
9.30am Welcome and introduction, W Wassif, National Audit Lead
9.35am National audit of the laboratory investigation of PSA for the diagnosis and monitoring of prostate cancer, Andrew Seggie and Abel Tesfai, Prostate Cancer UK
10.05am Detection, assessment, surveillance, and management of prostate cancer, Caroline Moore, Professor and Honorary Consultant Urological Surgeon University College Hospital, London
10.45am Patient perspective, Neil MacLachlan
11.00am Tea Break
11.15am National Audit on testosterone, Nicola Barlow, Black Country Pathology Services
11.45am Outcomes of testosterone treatment in pathological and functional male hypogonadism, Richard Quinton, Consultant Endocrinologist, Newcastle Hospitals Trust
12.25am Discussion
12.35am Regional audit presentations
1.05pm Lunch and poster session
2.05pm National audit on tumours markers, Louise Ward, Bedford Hospital NHS Trust and Peter West, South Thames Audit Group
2.35pm The provision of laboratory services for tumour markers, Cathie Sturgeon Department of Laboratory Medicine, Edinburgh Royal Infirmary
3.05pm Tea break
3.20pm Circulating DNA (ctDNA): A potentially transformative tumour marker, Michael Duffy Professor at Clinical Research Centre St Vincent's University Hospital, Dublin, Ireland
3.50pm Personalized medicine - clinical implications of molecular profiling of tumours, an update, Shahzad Qureshi Consultant Histopathologist, Bedfordshire Hospitals NHS Foundation Trust
4.20pm New oncological therapeutics - 50 ways to kill your cancer, Kathryn Hawkesford Consultant Medical Oncologist, Barts Health NHS Trust
5.00pm Discussion
5.10pm Feedback and closing remarks, W Wassif, National Audit Lead